X (Twitter) LinkedIn
    Saturday, December 9
    Login
    0 Shopping Cart
    X (Twitter) LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Deals & Transactions»Novo Holdings and Vivo Capital lead USD200m Series A investment in Esco Lifesciences Group
    Deals & Transactions

    Novo Holdings and Vivo Capital lead USD200m Series A investment in Esco Lifesciences Group

    June 1, 2021Updated:June 1, 20211 Min Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Novo Holdings has co-led with Vivo Capital the over-subscribed USD200 million Series A and Crossover round in Esco Lifesciences Group (Esco), a leading provider of life sciences tools and services.

    The financing will enable Esco to strengthen its position through organic and external growth and transformation, as well as invest in China, thus addressing some of the most dynamic market segments and geographies. Other investors include two Asian sovereign wealth funds and Singapore-based global investor, EDBI.

    Esco is a world-leading manufacturer of laboratory and biopharma equipment and IVF medical devices, with four divisions, namely, Scientific, Medical, Healthcare, and Aster, which offers mission-critical equipment and advanced solutions to a broad diversity of laboratories, clinics and bio-pharma production sites in over 100 countries, thus contributing to the future of life science research and manufacturing.

    Read more at Private Equity Wire

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    deals
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Animal drugs maker Dechra agrees to lower £4.5bn takeover by Swedish private equity firm EQT

    June 3, 2023

    Warburg and Advent in the lead to acquire Baxter’s biopharma unit

    May 13, 2023

    BlackRock Sells Asset-Backed Bonds From Credit Suisse’s Books

    April 14, 2023

    KKR buys stake in communications firm FGS Global

    April 11, 2023

    Comments are closed.

    Other Articles

    Core Industrial Partners portfolio co Incodema acquires Mark Two Engineering

    January 8, 2021

    Thoma Bravo leads $130m Series D round for mental health provider network Alma

    August 30, 2022

    Private equity financing of sports met with resistance after Super League fiasco

    May 25, 2021

    Legal tech startup LawVu closes seed round led by Shasta and AirTree Ventures

    May 4, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    X (Twitter) LinkedIn
    © 2023 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.


    Lost password?